|
|
|
|
|
|
|
|
|
|
|
|
|
03.08.26 - 17:09
|
Actualyze AI Emerges from Stealth with $7M Seed Round to Deliver Enterprises One Platform for Every AI Request (PR Newswire)
|
|
|
Backed by Storm Ventures, Canaan Partners, Morado Ventures, and AME Cloud Ventures, the platform gives enterprises one platform to govern, secure, operate, and optimize every AI request PASADENA, Calif., Aug. 3, 2026 /PRNewswire/ -- Actualyze AI emerged from stealth today announcing......
|
|
|
|
|
23.07.26 - 14:03
|
Bankwell Financial Group Reports Operating Results for the Second Quarter, Declares Third Quarter Dividend (Business Wire)
|
|
|
NEW CANAAN, Conn.--(BUSINESS WIRE)--Bankwell Financial Group, Inc. (NASDAQ: BWFG) reported GAAP net income of $12.4 million, or $1.52 per share for the second quarter of 2026, versus $11.3 million, or $1.41 per share, for the first quarter of 2026. The Company's Board of Directors declared a $0.20 per share cash dividend, payable August 21, 2026 to shareholders of record on August 10, 2026.
Discussion of Outlook; Bankwell Financial Group Chief Executive Officer, Christopher R. Gruseke:
"I'd like to congratulate our team for another outstanding quarter. Profitability continues to increase as we achieved a 1.46% Return on Average Assets and a 15.61% Return on Average Tangible Common Equity. We continue to execute key strategic objectives by meaningfully growing and improving our deposit base, accelerating loan growth, and establishing a more rate neutral balance sheet. We are particularly proud to note that as we continue to invest in our future, we have achieved a peer-leading 47.5% Efficiency Ratio...
|
|
|
|
|
|
|
15.07.26 - 15:03
|
NewLake Capital Partners Announces Board Transition (GlobeNewswire EN)
|
|
|
NEW CANAAN, Conn., July 15, 2026 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OTCQX: NLCP) (“NewLake” or “the Company”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that David Weinstein will resign from its Board of Directors, effective July 31, 2026....
|
|
|
|
|
|
|
09.07.26 - 14:03
|
Bankwell Financial Group, Inc. Announces Date of Second Quarter Earnings Conference Call (Business Wire)
|
|
|
NEW CANAAN, Conn.--(BUSINESS WIRE)--Bankwell Financial Group, Inc. (NASDAQ: BWFG), the holding company for Bankwell Bank, today announced that it will issue its earnings release for the quarter ended June 30, 2026, on Thursday July 23, 2026. Management will also host an audio webcast and conference call at 11:00 a.m. Eastern Time, on Thursday, July 23, 2026, to review the Company's financial performance and operating results.
The audio webcast link, along with the corresponding presentation slides, will be available on the Company's Investor Relations site (https://investor.mybankwell.com/news-market-data/event-calendar/default.aspx) prior to the beginning of the webcast. The webcast will also be archived on the Company's website for twelve months and can be accessed at any time during this period.
About Bankwell Financial Group, Inc.
Bankwell Financial Group, Inc. is the holding company for Bankwell Bank ("Bankwell"), a full-service commercial bank headquartered in New Canaan, CT. Bankwell offers its ...
|
|
|
06.07.26 - 22:12
|
Canaan Inc. Completes Transfer to Nasdaq Capital Market (PR Newswire)
|
|
|
Applies for additional 180-day minimum bid price compliance period SINGAPORE, July 6, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today announced that the Listing Qualifications Department of The Nasdaq Stock Market LLC......
|
|
|
|
|
|
|
|
|
17.06.26 - 11:06
|
Vedana Therapeutics Launches With $46 Million Series A Financing to Advance Next-Generation Migraine Therapies (Business Wire)
|
|
|
Targeting clinically validated pathways to enable patients to achieve freedom from migraine
Built by the world's foremost migraine experts and industry leaders
Financing co-led by Westlake BioPartners and Canaan PartnersSEATTLE--(BUSINESS WIRE)--Vedana Therapeutics (“Vedana”), a biotechnology company developing next-generation therapies for migraine prevention, today emerged from stealth with $46 million in Series A financing. The financing was co-led by Westlake BioPartners and Canaan Partners, with participation from Dawn Biopharma and Alexandria Venture Investments. Vedana's executive team, board, and advisors include leaders who discovered and developed multiple migraine therapies, including approved calcitonin gene-related peptide (CGRP) antibodies and the emerging pituitary adenylate cyclase-activating polypeptide (PACAP) drug class.
Proceeds from the financing will be used to advance Vedana's portfolio of internally discovered, potentially best-in-class, subcutaneously delivered antibodies t...
|
|
|
16.06.26 - 02:06
|
AttoTude Secures $52M in Series C Funding Round to Accelerate Interconnect Technology for Hyperscale Infrastructure (Business Wire)
|
|
|
New investment fast-tracks ASIC over Dielectric commercialization to meet surging AI market demand.MENLO PARK, Calif.--(BUSINESS WIRE)--AttoTude™ Inc., the pioneer of groundbreaking interconnect technology for AI infrastructure that uniquely enables the transmission of electrical signals directly over Dielectric fiber (i.e. ASIC over Dielectric), today announced it has raised $52 million in Series C funding led by The Westly Group. The Westly Group was joined in this funding round by new strategic investors Keysight, Allegis Capital, and DNX, with participation from existing investors including Sutter Hill Ventures, Mayfield, Canaan, and Wing Venture Capital. This latest investment brings AttoTude's total funding to $143 million.
“This financing marks a pivotal step as we transition AttoTude's ASIC over Dielectric interconnect technology from transformative innovation to product, with our first product demonstrations coming this fall,” said Dave Welch, CEO and co-founder, AttoTude. “We're excit...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
